1
|
Chen T, Yang Y, Huang Z, Pan F, Xiao Z, Gong K, Huang W, Xu L, Liu X, Fang C. Prognostic risk modeling of endometrial cancer using programmed cell death-related genes: a comprehensive machine learning approach. Discov Oncol 2025; 16:280. [PMID: 40056247 DOI: 10.1007/s12672-025-02039-8] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Submit a Manuscript] [Subscribe] [Scholar Register] [Received: 12/30/2024] [Accepted: 03/03/2025] [Indexed: 03/10/2025] Open
Abstract
BACKGROUND Endometrial cancer represents a significant health challenge, with rising incidence and complex prognostic challenges. This study aimed to develop a robust predictive model integrating programmed cell death-related genes and advanced machine learning techniques. METHODS Utilizing transcriptomic data from TCGA-UCEC and GSE119041 datasets, we employed a comprehensive approach involving 117 machine learning algorithms. Key methodologies included differential gene expression analysis, weighted gene co-expression network analysis, functional enrichment studies, immune landscape evaluation, and multi-dimensional risk stratification. RESULTS We identified 10 critical genes (PTGIS, TIMP3, SRPX, SNCA, HIC1, BAK1, STXBP2, TRIB3, RTKN2, E2F1) and constructed a prognostic model with superior predictive performance. The StepCox[forward] + plsRcox algorithm combination demonstrated excellent predictive accuracy (AUC > 0.8). Kaplan-Meier analysis revealed significant survival differences between high- and low-risk groups in both training (HR = 3.37, p < 0.001) and validation cohorts (HR = 2.05, p = 0.021). The model showed strong correlations with clinical characteristics, immune cell infiltration patterns, and potential therapeutic responses. CONCLUSIONS This study presents a novel, comprehensive approach to endometrial cancer prognosis, integrating machine learning and molecular insights to provide a more precise risk stratification tool with potential clinical translation.
Collapse
Affiliation(s)
- Tianshu Chen
- Department of Gynecology, Taihe Hospital, Hubei University of Medicine, Shiyan, No. 32 Renmin, South Road, 442000, Hubei, China
| | - Yuhan Yang
- Department of Gynecology, Taihe Hospital, Hubei University of Medicine, Shiyan, No. 32 Renmin, South Road, 442000, Hubei, China
| | - Zhizhong Huang
- Department of Gynecology, Taihe Hospital, Hubei University of Medicine, Shiyan, No. 32 Renmin, South Road, 442000, Hubei, China
| | - Feng Pan
- Department of Gynecology, Taihe Hospital, Hubei University of Medicine, Shiyan, No. 32 Renmin, South Road, 442000, Hubei, China
| | - Zhendi Xiao
- Department of Gynecology, Taihe Hospital, Hubei University of Medicine, Shiyan, No. 32 Renmin, South Road, 442000, Hubei, China
| | - Kunxue Gong
- Department of Gynecology, Taihe Hospital, Hubei University of Medicine, Shiyan, No. 32 Renmin, South Road, 442000, Hubei, China
| | - Wenguang Huang
- Department of Gynecology, Taihe Hospital, Hubei University of Medicine, Shiyan, No. 32 Renmin, South Road, 442000, Hubei, China
| | - Liu Xu
- Department of Gynecology, Taihe Hospital, Hubei University of Medicine, Shiyan, No. 32 Renmin, South Road, 442000, Hubei, China
| | - Xueqin Liu
- Department of Gynecology, Taihe Hospital, Hubei University of Medicine, Shiyan, No. 32 Renmin, South Road, 442000, Hubei, China.
| | - Caiyun Fang
- Department of Gynecology, Taihe Hospital, Hubei University of Medicine, Shiyan, No. 32 Renmin, South Road, 442000, Hubei, China.
| |
Collapse
|